{"pageContent": "Purpose: Time to metastasis is often used as a surrogate parameter of treatment success in clinical trials for prostate cancer. However, it has not been shown that there is a clear correlation between time to metastasis and overall survival. Our objective was to evaluate the impact of time to metastasis on OS in patients with prostate cancer.", "metaData": {"source": "[News aspects on surgical management of localized prostate cancer]\nhttps://pubmed.ncbi.nlm.nih.gov/19465331/"}}